ES468935A1 - Un metodo de preparacion de una cepa de virus vivo de la gastroenteritis transmisible. - Google Patents

Un metodo de preparacion de una cepa de virus vivo de la gastroenteritis transmisible.

Info

Publication number
ES468935A1
ES468935A1 ES468935A ES468935A ES468935A1 ES 468935 A1 ES468935 A1 ES 468935A1 ES 468935 A ES468935 A ES 468935A ES 468935 A ES468935 A ES 468935A ES 468935 A1 ES468935 A1 ES 468935A1
Authority
ES
Spain
Prior art keywords
tge
preparing
virus strain
transmissible gastroenteritis
live vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES468935A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Gloeilampenfabrieken NV filed Critical Philips Gloeilampenfabrieken NV
Publication of ES468935A1 publication Critical patent/ES468935A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C12N2770/20064—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/815—Viral vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES468935A 1977-04-21 1978-04-19 Un metodo de preparacion de una cepa de virus vivo de la gastroenteritis transmisible. Expired ES468935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7704348A NL7704348A (nl) 1977-04-21 1977-04-21 Werkwijze voor het bereiden van een geattenueer- de transmissible gastroenteritis(tge)-virusstam voor toepassing in levende vaccins.

Publications (1)

Publication Number Publication Date
ES468935A1 true ES468935A1 (es) 1978-12-01

Family

ID=19828409

Family Applications (1)

Application Number Title Priority Date Filing Date
ES468935A Expired ES468935A1 (es) 1977-04-21 1978-04-19 Un metodo de preparacion de una cepa de virus vivo de la gastroenteritis transmisible.

Country Status (14)

Country Link
US (1) US4159319A (es)
JP (1) JPS53133629A (es)
AU (1) AU525486B2 (es)
BE (1) BE866150A (es)
CA (1) CA1124646A (es)
DE (1) DE2817299A1 (es)
ES (1) ES468935A1 (es)
FR (1) FR2388050A1 (es)
GB (1) GB1597259A (es)
IT (1) IT1094413B (es)
NL (1) NL7704348A (es)
PL (1) PL109646B1 (es)
SU (1) SU971108A3 (es)
YU (1) YU93178A (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601251A1 (fr) * 1986-07-09 1988-01-15 Pensaert Maurice Agent viral non pathogene pour la prevention de la gastroenterite transmissible porcine, son obtention et son utilisation comme vaccin.
WO1994007514A1 (en) 1992-09-29 1994-04-14 Inhale Therapeutic Systems Pulmonary delivery of active fragments of parathyroid hormone
EP1462096B1 (en) 1994-03-07 2008-12-10 Nektar Therapeutics Methods and compositions for pulmonary delivery of insulin
US20030113273A1 (en) * 1996-06-17 2003-06-19 Patton John S. Methods and compositions for pulmonary delivery of insulin
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
SI1458360T1 (sl) 2001-12-19 2011-08-31 Novartis Ag Pulmonalno dajanje aminoglikozidov
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
ES2436317T3 (es) 2010-05-07 2013-12-30 Deutsches Krebsforschungszentrum Parvovirus de roedor modificado capaz de propagarse y difundirse en gliomas humanos
PL2746790T3 (pl) 2012-12-24 2020-05-18 Uniwersytet Morski W Gdyni Sposób i układ do pomiaru własnych i wzajemnych rezystancji termicznych elementu indukcyjnego

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth
US3704203A (en) * 1967-08-24 1972-11-28 Diamond Lab Inc Transmissible gastroenteritis vaccines and methods of producing the same
US3585108A (en) * 1969-07-14 1971-06-15 Diamond Lab Inc Transmissible gastroenteritis vaccines and methods of producing the same
US4046875A (en) * 1975-07-14 1977-09-06 Richardson-Merrell Inc. Attenuated TGE virus

Also Published As

Publication number Publication date
BE866150A (fr) 1978-10-19
YU93178A (en) 1983-04-30
IT1094413B (it) 1985-08-02
JPS53133629A (en) 1978-11-21
DE2817299A1 (de) 1978-10-26
SU971108A3 (ru) 1982-10-30
GB1597259A (en) 1981-09-03
IT7822442A0 (it) 1978-04-18
FR2388050B1 (es) 1980-10-31
AU3520378A (en) 1979-10-25
FR2388050A1 (fr) 1978-11-17
US4159319A (en) 1979-06-26
AU525486B2 (en) 1982-11-11
PL109646B1 (en) 1980-06-30
NL7704348A (nl) 1978-10-24
CA1124646A (en) 1982-06-01
PL206218A1 (pl) 1979-03-26

Similar Documents

Publication Publication Date Title
ES468935A1 (es) Un metodo de preparacion de una cepa de virus vivo de la gastroenteritis transmisible.
DE3266201D1 (en) Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines and infectious-bronchitis virus strain
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
EP0024956A3 (en) Genetically attenuated bacterial vaccines, method of preparing them, method of protecting animals and humans against infectious diseases and bacterial strains used in it
NL930133I2 (nl) Vaccin tegen hepatitis B virus, werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin.
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
NZ195184A (en) Live feline infectious peritonitis (fip) virus vaccine; fip virus atcc no.vr-2004
ES467557A1 (es) Un procedimiento para la preparacion de una nueva vacuna queprotege a las aves ponedoras de huevos contra la enfermedad del descenso de la produccion de huevos.
EP0003692A3 (en) E. coli enterotoxin vaccine for veterinary & human use and process for its preparation
EG13435A (en) High molecular weight meningococal group c.vaccine and method for preparation thereof
DE3064656D1 (en) Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strains
DE3071225D1 (en) Influenza virus vaccines, process for preparing them and process for propagating influenza viruses
JPS5440178A (en) Growth promoting agent for domestic animals
ZA751963B (en) Method for immunizing nursing piglets against transmissible gastroenteritis (tge) virus
EP0115442A3 (en) Vaccine and its use against pseudorabies virus
GB2006013B (en) Method and autoclave for sterilisation using formalin
JPS53123346A (en) Treating method for toe of weld
ES446637A1 (es) Procedimiento para la preparacion de vacunas acelulares.
GB2000028A (en) Vaccines Containing Vibrio Cholerae Choleragen or a Toxoid thereof or Sub-unit A or B thereof
DE3361138D1 (en) Ozone inactivated organisms as vaccines
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
DK340079A (da) Vaccine og vaccination for svinedysenteri
JPS5545653A (en) Vaccine for preventing and treating aminal and poultry clostridium
GEP19960537B (en) Method of inducing male sterility in cotton plants
JPS53142829A (en) Delivery and recognizing system for real time graph